Few data regarding early developmental changes in cerebral (blood-to-brain) glucose transport (CTXgk) and
Michaelis-Menten constants from the best fit to the measured data produced values of K, = 6.0 J..l mol mL-1 and T max = 32.6 J..l mol 100 g-I min-I. These values for K, in the developing human brain are similar to those that have been reported for the mature brain of adolescent and adult humans and adult nonhu man primates, indicating the affinity of the glucose transport protein for D-glucose is similar. However, T m a x is approxi mately one third to one half of the comparable values for ma ture brain, indicating a reduced number of available luminal transporters. Key Words: Neonate-Infant-Cerebral glucose metabolism-Cerebral glucose transport-Blood-brain barrier.
lescence and then decline to adult levels (Gleason et aI., 1989; Chugani et aI., 1991; Abrams et aI., 1984) .
Few data regarding CTX g 1c and CMR g 1c during early brain development are available for humans. Measure ments of CMR g 1c have been reported in a few newborn term infants, most of whom have had hypoxic-ischemic encephalopathy (Blennow et aI., 1995; Suhonen-Polvi et aI., 1995; Chugani et aI., 1987) . No measurements of CMR g1 c in preterm infants or measurements of CTX g l c have been reported.
METHODS

Subjects
Potential subjects were identified by monitoring all admis sions to the Neonatal Intensive Care Unit at St. Louis Chil dren's Hospital. Infants were considered eligible for study only when the attending neonatologist considered that the infant's respiratory, circulatory, and metabolic status was stable for transport to the positron emission tomography (PET) scanner.
Infants were transported to the PET facility in an Ohio Trans port Incubator. The incubator was equipped with (I) a monitor to indicate respiratory rate, cardiac rate, ECG, and body tem perature; (2) a pediatric respirator for intubated infants requir ing ventilatory support, including tanks of oxygen and com pressed air with a blender to provide the desired mixture; (3) an automatic syringe-type pump to deliver continuous, accurate intravenous infusions; and (4) Infants were fasted for at least 1 hour before the PET study.
No change was made in the infants' oral or intravenous intake to manipulate the plasma glucose concentration for the pur poses of this study. In our neonatal intensive care unit, there is no fixed protocol regarding the need for glucose supplementa tion to treat hypoglycemia, but values below 1.7 f..l mol mL-1 generall y are treated.
Positron emission tomography
Subjects were positioned in a Siemens ECAT 961 EXACT HR PET scanner (Siemens Medical Systems, Inc., Hoffman Estates, IL, U.S.A.) such that the head was in the approximate center of the field of view. Individual attenuation measure ments were made with 68Ge_ 68Ga rotating rod sources. Emis sion data was acquired in the three-dimensional mode (inter slice septa retracted). Scatter from outside the field of view was minimized by using a semicylindrical lead cradle (Ollinger et aI., 1996) .
The CBF was measured with a 40-second emission scan after 0.5 mCi kg-I of H2150 in 0.5 mL of saline was injected manu ally over 2 to 5 seconds into a peripheral vein. Arterial blood samples of 0.1 to 0.2 mL were drawn into syringes from the umbilical artery catheter. The blood radioactivity and scan data were corrected for physical decay of 150. The CBF was cal culated using an adaptation of the Kety autoradiographic method. We have published details of this method in newborn infants (Altman et aI., 1988) .
Measurements of CTXglc and CMRglc were performed after slow intravenous injection of 0.1 mCi kg-I of I-IIC-D-glucose (Powers et aI., 1995) . Dynamic PET acquisition was carried out for 1 hour. Forty-four separate frames were collected: 16 30second, 8 60-second, 16 l20-second, and 4 180-second frames.
During this scan, arterial blood samples of 0.1 to 0.2 mL were drawn from the arterial catheter.
Arterial blood gases were measured during the PET study with an IL 1306 pH/Blood Gas Analyzer (Instrumentation Laboratory, Lexington, MA, U.S.A.). Capillary plasma glucose [Glc J was measured from a heel stick sample after the end of data P acquisition. Capillary glucose concentration correlates closely with arterial concentration in fasted subjects (Larsson Cohn, 1976) . Total blood loss, including samples for arterial blood gases, did not exceed 5% of the infant's total blood volume.
All radiopharmaceuticals were produced in the Washington University School of Medicine cyclotron facility (Dence et aI., 1993; Welch et aI., 1985) .
The radiation exposure associated with these PET studies is equivalent to a uniform whole-body exposure of 276 mrem, 
Data analysis
All images were reconstructed using the PROMIS algorithm with scatter correction using the single-scatter simulation method (Watson et aI., 1996; Ollinger, 1996; Kinahan et aI., 1989) . Mean transaxial resolution is 3.7 mm full width half maximum at the center and 4.6 mm at 10 cm off center. Mean axial resolution is 4.4 mm full width half maximum at the center and 6.4 mm at 10 cm off center (Wienhard et aI., 1994) .
Regional physiologic data were calculated for a 44 mm wide
x 44 mm long x 15.6 mm thick rectangular region centered at a midhemispheric slice encompassing insular cortex, basal gan glia, and adjacent white matter. I-IIC-D-glucose PET time radioactivity curves were generated from the dynamic PET data using a previously determined conversion factor relating PET radioactivity measurements to blood radioactivity measured by a scintillation counter. The PET and arterial whole blood time activity data were processed using a modified Marquardt pa rameter estimation routine and a four-compartment model (Powers et aI., 1995) . Compartment I represents the intravas cular compartment of the brain (arterial, capillary, and venous) containing free glucose that can exchange with free glucose in the brain, compartment 2 represents free glucose in the brain, compartment 3 represents glucose metabolites in the brain, and compartment 4 represents the vascular space to which metabo lites go after they leave the brain. Five parameters were esti mated: four rate constants (k*2 1 ' k*lz, k*32 ' and k* 43) and the volume of the intravascular compartment (VI). The time shift (To) between the arrival of radioactivity at the umbilical artery and at the brain was determined during the H2150 scan by observing the sudden increase in total coincidence events in the head as recorded at I-second intervals by the scanner. In one case, this time shift could not be accurately determined and was estimated as a sixth parameter.
Since the parameter estimation was based on time radioactivity data from whole blood, we calculated the glucose concentration of whole blood [GlcwbJ = [GlcpJ (I -0.30 . hematocrit) (Dillon, 1965) . Hematocrit was calculated from the hemoglobin concentration using a mean corpuscular hemoglo bin concentration of 0.31 (Letsky, 1992) . Implicit in these cal culations is the assumption that there exists rapid equilibration between plasma and intraerythrocytic glucose. This has been demonstrated for human blood (LeFevre et aI., 1997; Mu rphy, 1960) .
The parameter estimation results were used to calculate the following biological quantities:
We also performed parameter estimation for the two Micha elis-Menten constants Kt and T max; based on the measured CTXglc and the calculated brain capillary plasma glucose con centration (CJ:
Because of the small number of data points, we did not attempt to estimate the diffusion constant Kd, and it was set equal to O. 
RESULTS
Studies were carried out on six preterm newborn in fants ( Table 1 ). All infants had infantile respiratory dis tress syndrome and were intubated endotracheally shortly after delivery. They all had been cared for in the Neonatal Intensive Care Unit with close attention to maintenance of blood pressure and tissue oxygenation since shortly after birth. None showed evidence of pa renchymal brain damage by cranial ultrasound, although one had unilateral subependymal hemorrhage and one had unilateral intraventricular hemorrhage. All infants had indwelling umbilical arterial and intravenous cath eters placed for clinical intensive care. All four infants with patent ductus arteriosus had umbilical arterial P02 greater than 90 mm Hg, indicating that there was no significant right-to-Ieft shunt at the time of the PET study. Therefore, the umbilical arterial blood samples are a valid representation of the arterial input function to the brain (Altman et aI., 1988) .
Representative images ( Fig. 1) and regional II C time radioactivity curve (Fig. 2) from one of the subjects are shown. As can be seen from this example, the time radioactivity curves derived from the estimated param eters fit the measured regional time activity well, espe cially in the early part of the curve, which is critical for the accurate estimation of V 1. The two most critical rate constants are k*2 1 (for the calculation of CTX g1 J and k* 43 (for the calculation of CMR gI J. The mean coeffi cients of variation for the estimates of these three param eters were all less than 10%: VI 5.4%, k*2 1 9.9%, and k* 43 7.2%. These values are comparable with those that we obtained in our experimental validation study: V I 7.7%, k*2 1 11.1%, and k*43 8.2% (Powers et aI., 1995) .
Mean CMR g l c was 8.8 fLmol 100 g� 1 min� 1 ( Table 2) . The CMR g l c did not correlate with plasma glucose con centration (r = .31 5, P = .543). CTX g l c showed a sig nificant correlation with plasma glucose concentration (r = .836, P = .038). The CTX g1 c began to approach CMR g l c as the plasma glucose concentration fell toward 3.6 fLmol mL � I (Fig. 3) .
Estimation of the Michaelis-Menten constants from the best fit to the measured data produced values of Kt = 6.0 fLmol mL� 1 and T max = 32.6 fLmol 100 g� l min� 1 (Fig. 4) . The standard error of the estimates is 3.4 (55%) for K( and 10.3 (27%) for T max'
DISCUSSION
Performance of these PET measurements in these small preterm infants presented formidable technical and logistical problems. Because of the presumed long-term risk, the amount of radioactivity that can be used under Food and Drug Administration regulations is only one tenth that allowed in adults. Only large regions of interest provide adequate counting statistics for accurate param eter estimation. The PET studies themselves require suf ficient blood samples to generate reasonable blood. time radioactivity curves. All ancillary blood drawing must be kept to a minimum. We therefore collected only a single heel-stick sample in a capillary tube for plasma glucose determination. Whereas multiple samples drawn from the arterial line would have been preferable, the increase in blood loss, albeit only a few milliliters, represented a substantial addition blood loss in some of these infants whose total blood volume is only 50 mL. Since these infants were fasted, we have no reason to believe that the plasma glucose values varied substantially during the procedure.
Values for CBF of 6.6 to 15 mL 100 g� l min� 1 were similar to those we have previously measured in preterm infants. Values for VI estimated from the dynamic PET data were similar to direct measurements of cerebral blood volume of 1.5 to 3.1 mL 100 g� 1 that we have made in other preterm infants (Altman et aI., 1993; Alt man et aI., 1988) . The CMR g l c in these preterm newborn infants was approximately one third the normal adult whole-brain value of 25 fLmol 100 g� 1 min� 1 obtained with the Kety Schmidt technique (Madsen et aI., 1993; Siesjo, 1978) . These substantially reduced rates for CMR g l c in preterm infants compared with adults are consistent with data reported from fetuses of other mammalian species (Abrams et aI., 1984; Dyve et aI., 1991; Gleason et aI., 1989). Total body glucose metabolism of the preterm infant is approximately 40 /-Lmol kg-1 min-1 (Tyrala et aI., 1994) . At this stage of' development, the brain weighs approximately 14% of the body weight (Gruenwald and Minh, 1960) . Thus, based on our mean CMR g1 c of 8.8 /-Lmol 100 g-l min-I , the brain accounts for about 30% of total body glucose utilization for infants this size. This is substantially less than the 50% utilization by the brain in adults (Dineen et aI., 1992) . Blennow and coworkers report cortical CMR g 1c of 5.5 to 24.1 /-Lmol 100 g-l min-1 measured at 2 to 3 days of life in three term newborn infants with hypoxic-ischemic encephalopathy (Blennow et aI., 1995) . Suhonen-Polvi and others report whole-brain CMR g 1c of 9.0 to 25.6 /-Lmol 100 g-l min-1 measured within the neonatal period in seven infants taken from a study of hypoxic-ischemic brain injury and severe neonatal hypoglycemia (Suho nen-Polvi et aI., 1995). Our data from preterm infants are within the lower portion of the ranges reported by these investigators. Hypoxic-ischemic damage to the imma- ture rat brain causes an increase in both CMR g 1 c and expression of blood-brain barrier GLUT1 (Vannucci et aI., 1996; Vannucci et aI., 1994a) . These changes are largely resolved after 24 hours. In the infants that we studied, there was no evidence of parenchymal brain damage by cranial ultrasound. Careful attention had been paid to maintenance of oxygenation and perfusion in all infants since birth 4 to 7 days before. Although we can not rule out some degree of hypoxic-ischemic brain in jury at birth, we believe that our findings primarily re flect the normal metabolic status of the preterm brain rather than a pathologic response to hypoxic-ischemic injury.
Interpretation of these data with regard to energy me tabolism must be done cautiously. As opposed to the steady state in adult brain, the fetal brain is growing and uses intermediary compounds of glucose metabolism for synthesis of complex lipids (Lajtha et aI., 1981 ) . The portion of net cerebral glucose uptake that goes to syn thesis of new compounds retained in the brain cannot be directly determined from this study. However, an indi rect assessment of this can be obtained from the rate constant k* 43' which describes the fractional rate of the labeled metabolite pool that leaves the brain. The value of .01 8 ± .006 min-I that we obtained for these preterm infants is almost identical to the values of .01 85 ± .003 that we obtained in macaques and of .020 ± .001 that we have recently measured in normal adult humans (Powers et aI., 1997; Powers et aI., 1995) . The similarity of these values suggests that most of the glucose carbons taken up by the preterm human brain, like adult brain, are me tabolized and excreted. The capacity of the blood-brain barrier to transport glucose is reduced in fetal and newborn animals (Fugl sang et aI., 1986; Dyve et aI., 1991; Cremer et al., 1979; Vannucci et aI., 1994b; Cornford et aI., 1994; Daniel et aI., 1978) . Measurements of Kt and T m ax generally have shown a reduction in T m ax with no significant alteration in Kt (Cremer et aI., 1979; Cornford et aI., 1994; Daniel et aI., 1978) , although changes in Kt also have been reported (Fuglsang et aI., 1986) . The blood-brain glu cose transport protein GLUTI is present in the vascular endothelium of preterm human infants of 24 to 33 weeks gestational age (Mantych et aI., 1993) . As would be ex pected for the same glucose transport protein, our value of Kt = 6.0 f.1mol mL -I in the developing human brain is similar to those that have been reported for mature ) ; CMR g lc, cerebral metabolic rate of glucose; CTX g lc, cerebral (blood-to-brain) transport rate for glucose. brains of adolescent (4.9 !-Lmol mL-I) and adult humans (4.1 !-Lmol mL -I ), and also is similar to the value we have previously reported in adult nonhuman primates (5.8 !-Lmol mL -I) (Powers et aI., 1995; Blomqvist et aI., 1991; Gruetter et a!., 1992) . However, at 32.6 !-Lmol 100 g-l min-I , T max in the preterm human brain is approximately one third to one half the values reported for mature hu mans of 62 and 110 !-Lmol 100 g-l min-1 and adult non human primates of 87 !-Lmol 100 g-I min-I (Powers et aI., 1995; Blomqvist et aI., 1991; Gruetter et aI., 1992) . This reduction in transport capacity indicates a reduced num ber of available luminal transporters. This may reflect the reduced vascularity of the developing brain (Morin et aI., 1988; Zeller et aI., 1996) . Blood-brain transport was correlated with plasma glu cose concentration, as predicted by the Michaelis Menten equation. The transport rate exceeded metabolic demand at all plasma glucose values that we studied. The ratio of CTX g \c:CMR gl c approached unity as plasma glu cose declined toward 3.6 !-Lmol mL -I . Based on these data, transport limitation of metabolism can be expected to occur at a plasma glucose level of approximately 3.0 !-Lmol mL-l.
